Researchers warn that the public, policy makers and even clinicians are not aware of the growing problem of liver cancer.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver condition to date, with an estimated global prevalence of 38%.1 The progressive and inflammatory stages of ...

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.

Sixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

More than 500,000 annual liver cancer diagnoses could be prevented with global interventions aimed at reducing viral hepatitis B and C, alcohol consumption and a disease strongly associated with ...

Higher cumulative exposure to uric acid is independently and dose-dependently associated with an increased risk for MASLD. Cumulative uric acid (UA) exposure is an independent risk factor for ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called ...

A recent study reveals that 60% of liver cancer cases are preventable by addressing key risk factors such as viral hepatitis, ...

Poor dietary habits and obesity are key contributors to non-alcoholic fatty liver disease (NAFLD).leading to inflammation and ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), affecting approximately 30% of the global population, represents a spectrum of liver disorders ranging from simple steatosis to ...